{"id":47439,"date":"2022-08-18T15:02:01","date_gmt":"2022-08-18T13:02:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/"},"modified":"2022-08-18T15:02:01","modified_gmt":"2022-08-18T13:02:01","slug":"former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/","title":{"rendered":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.\u2014a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases\u2014has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira\u2019s founder, Mario Danek, will transition to the role of Chief Technology Officer.\n<\/p>\n

<\/a><\/p>\n

\nQuigley spent 16 years at Altria Group, with seven years as President & CEO at Altria\u2019s Smokeless and Innovative Products\/Vapor Businesses. Quigley has been an active investor in both the cannabis and alcohol spaces and sits on the boards of Mustgrow Biologics and Belle Isle Craft Spirits.\n<\/p>\n

\nWith Respira in the midst of securing financing for clinical trials, Danek made a significant change to the structure of the company\u2019s leadership team. Quigley\u2019s background as a successful business leader and Fortune 150 CEO in the space will help drive Respira to its next phase as it advances to an IND submission to begin human clinical trials. This transition will enable Danek to focus on the technology behind Respira, concentrating on inventing and refining its innovative inhalation device across multiple potential indication areas and target markets.\n<\/p>\n

\nRespira, where Quigley spent the past two years as COO, is a California venture-backed health tech company focused on commercializing proprietary inhalation device technologies to improve patient outcomes. The company is currently engaged with FDA CEDR to pursue a combination product authorization as the first inhalable prescription smoking cessation therapy.\n<\/p>\n

\nAbout Respira Technologies, Inc.<\/b>\n<\/p>\n

\nRespira, based in Los Angeles, was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies.\n<\/p>\n

\nThe company\u2019s key product, the RespiRx\u2122, is the first orientation-agnostic, portable VMN device that effectively operates in any position held by the patient. Respira sees significant opportunity to utilize its drug delivery technologies to improve the treatment of Asthma, COPD, Vaccine Delivery, Pain Management, and several generic as well as select investigational new drugs with safe and effective inhalable drug delivery mechanisms that only the RespiRx\u2122 can deliver.\n<\/p>\n

\nRespira is backed by venture firms Blue Ledge Capital, DG Ventures, Evolution VC Partners, and Poseidon Asset Management.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations:<\/b>
Respira Technologies, Inc.
\n
IR@Respiratechnologies.com<\/a>\n<\/p>\n

\nMedia Relations:
\n
<\/b>Richard Laermer
\n
RLM PR
\n
212-741-5106 X 216
\n
Respira@RLMpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.\u2014a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases\u2014has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira\u2019s founder, Mario Danek, will transition to the role of Chief Technology Officer. Quigley spent 16 years … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47439","6":"format-standard","7":"category-industry"},"yoast_head":"\nFormer Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.\u2014a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases\u2014has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira\u2019s founder, Mario Danek, will transition to the role of Chief Technology Officer. Quigley spent 16 years ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T13:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO\",\"datePublished\":\"2022-08-18T13:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005051\\\/en\\\/1546900\\\/21\\\/respira-logo-b3-09-hires.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/\",\"name\":\"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005051\\\/en\\\/1546900\\\/21\\\/respira-logo-b3-09-hires.jpg\",\"datePublished\":\"2022-08-18T13:02:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005051\\\/en\\\/1546900\\\/21\\\/respira-logo-b3-09-hires.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220818005051\\\/en\\\/1546900\\\/21\\\/respira-logo-b3-09-hires.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/","og_locale":"en_US","og_type":"article","og_title":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.\u2014a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases\u2014has appointed former Altria Group executive and current Respira COO Brian Quigley as its new Chief Executive Officer. Respira\u2019s founder, Mario Danek, will transition to the role of Chief Technology Officer. Quigley spent 16 years ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-18T13:02:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO","datePublished":"2022-08-18T13:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/"},"wordCount":394,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/","url":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/","name":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg","datePublished":"2022-08-18T13:02:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220818005051\/en\/1546900\/21\/respira-logo-b3-09-hires.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/former-top-altria-exec-takes-the-reigns-at-respira-technologies-brian-quigley-is-appointed-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Former Top Altria Exec Takes the Reigns at Respira Technologies: Brian Quigley Is Appointed CEO"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47439","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47439"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47439\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47439"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47439"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47439"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}